Therapeutic area
Biotherapeutic
Background info
Indication
Advantages
Intellectual property
Owner/lead
What the technology does
A ligand trap that specifically blocks Ang-2 activity
Advantage
A highly specific ligand trap for Ang2, evolved using a proprietary directed evolution technique, that does not block the protective activity of Ang1.
Main application field
Treatment of pathological angiogenesis, e.g. diabetic retinopathy.
Usage
Therapeutic
Status
Technology ready for evaluation and collaborative development2
Intellectual Property
Priority UK filing made 20/12/2012. PCT/GB2013/053392
Offering
Exclusive or non-exclusive licence